Future of the drug label: Perspectives from a multistakeholder dialogue.
Br J Clin Pharmacol
; 85(10): 2442-2445, 2019 10.
Article
en En
| MEDLINE
| ID: mdl-31317570
ABSTRACT
Regulating drugs does not end when market access has been granted. Monitoring drugs over the life cycle has become state of the art, inherent to evolving legislation and societal need. Here, we explore how the drug label could move along in a changing playing-field and become a sustainable label for the future. A dialogue between academia, government, the pharmaceutical industry and patient/societal organizations was organized by the Regulatory Science Network Netherlands. This is their view.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Control de Medicamentos y Narcóticos
/
Industria Farmacéutica
/
Etiquetado de Medicamentos
Límite:
Humans
País/Región como asunto:
Europa
Idioma:
En
Revista:
Br J Clin Pharmacol
Año:
2019
Tipo del documento:
Article
País de afiliación:
Países Bajos